The effect of rejection and graft-versus-host disease on small intestinal microflora and bacterial translocation after rat small bowel transplantation.
Bacterial translocation and the development of sepsis after small bowel transplantation may be promoted by immunological damage to the intestinal mucosa or by quantitative and qualitative changes in intestinal microflora. This study assessed the effects of rejection, graft-versus-host disease (GVHD) and immunosuppression on intestinal microflora and bacterial translocation after heterotopic rat small bowel transplantation. Isografts, allografts with and without CsA immunosuppression, and the semi-allogeneic parent to the F1 hybrid GVHD model were studied. Intestinal microflora in graft and host loops and bacterial translocation to host organs and the graft mesenteric lymph node were determined. Bacterial colonies were counted and individual colonies identified using API 20E nutrient and fermentation indicator techniques. Colony counts in isografts and allografts were significantly higher than in the native intestine, whereas there was a massive overgrowth in the native intestine in the GVHD group. The species profile for the host and graft loops was similar in animals that had received isografts, allografted animals receiving CsA, and animals undergoing GVHD. However, there was a large increase in Staphylococcus epidermidis in animals with rejection. Bacterial translocation was not detected in isografted animals, but was observed in all other animal groups, with S. epidermidis being the most prevalent organism. These findings demonstrate that rejection and GVHD are associated with shifts in intestinal microflora toward potentially pathogenic organisms and that bacterial translocation into recipient tissues poses a major threat for the development of sepsis.
Price
B A
BA
Professorial Surgical Unit, St. Bartholomew's Hospital, London.
Cumberland
N S
NS
Clark
C L
CL
Pockley
A G
AG
Lear
P A
PA
Wood
R F
RF
D000818:Animals; D001419:Bacteria / Q000302:isolation & purification*; D001424:Bacterial Infections / Q000209:etiology; D018407:Bacterial Physiological Phenomena; D005839:Gentamicins / Q000627:therapeutic use; D006084:Graft Rejection; D006086:Graft vs Host Disease / Q000209:etiology*; D007421:Intestine, Small / Q000382:microbiology* / Q000637:transplantation*; D008297:Male; D009068:Movement; D011292:Premedication; D051381:Rats; D011919:Rats, Inbred Strains; D014185:Transplantation, Isogeneic
D005839:Gentamicins